Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New tech aims to tame blood sugar in High-Risk dialysis patients

NCT ID NCT06641765

Summary

This study is testing whether using a continuous glucose monitor (CGM) can help diabetic patients on dialysis better manage their blood sugar levels. It compares three groups: standard finger-prick checks, using a CGM part-time, or using a CGM full-time over nine months. The goal is to see if more detailed glucose data helps doctors adjust treatments to keep patients in a healthy range more often and reduce dangerous lows.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Herlev Hospital

    Herlev, 2730, Denmark

  • Holbæk Sygehus

    Holbæk, 4300, Denmark

  • North Zealand Hospital, Hillerød

    Hillerød, 3400, Denmark

  • Rigshospitalet

    Copenhagen, 2100, Denmark

  • Zealand University Hospital

    Roskilde, 4000, Denmark

Conditions

Explore the condition pages connected to this study.